Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
253 hedge funds and large institutions have $2.62B invested in Cantel Medical Corporation in 2018 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 88 increasing their positions, 96 reducing their positions, and 60 closing their positions.
325% more call options, than puts
Call options by funds: $1.27M | Put options by funds: $298K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 96
12% less funds holding
Funds holding: 286 → 253 (-33)
22% less capital invested
Capital invested by funds: $3.35B → $2.62B (-$728M)
48% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 60
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$54.9M |
| 2 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$41.8M |
| 3 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$20.4M |
| 4 |
Impax Asset Management Group
London,
United Kingdom
|
+$18.4M |
| 5 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$17.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
-$60.3M |
| 2 |
O
OppenheimerFunds
New York
|
-$16M |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
-$14.9M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$10.8M |
| 5 |
Morgan Stanley
New York
|
-$10.6M |
CMD Hedge Fund Activity: Q4 2018 in Review
253 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q4 2018, worth a combined $2.62B — down 22% from $3.35B a quarter earlier.
Sellers outnumbered buyers: 60 funds closed out of CMD and 31 opened new positions — a net loss of 29 holders — while 96 trimmed existing stakes and 88 added.
The largest buyer was Champlain Investment Partners, adding an estimated $54.9M. The largest seller was EARNEST Partners, cutting an estimated $60.3M.
- 253 institutional investors held Cantel Medical Corporation (CMD) as of Q4 2018, down from 286 in Q3 2018.
- Funds reported $2.62B of Cantel Medical Corporation stock for Q4 2018, down 22% quarter-over-quarter.
- 31 funds opened new Cantel Medical Corporation positions in Q4 2018 and 60 closed out, a net change of -29 holders.
- The largest Cantel Medical Corporation buyer in Q4 2018 was Champlain Investment Partners, an estimated $54.9M added.
- The largest Cantel Medical Corporation seller in Q4 2018 was EARNEST Partners, an estimated $60.3M sold.
Based on aggregated 13F filings for Q4 2018.